OVERVIEW

TO BE THE GLOBAL LEADING THERAPEUTICS COMPANY

The ultimate goal of MDimune Inc. is to provide an innovative platform technology that can revolutionize the paradigm of human therapeutics by achieving target-specific delivery of effective drugs. The precision of this novel technology will enable safer and more effective treatments of many debilitating human diseases and bring hope to patients.

BUSINESS

Business Domain

Anti-cancer & CNS (including Rare disease) Global Collaborations Gene Therapy (mRNA, siRNA, miRNA, etc.) PIDO (Platform Inside Development Outside)

VIEW MORE >

Extensive Collaborations

Global Open Innovation Collaborative Pipelines Sub-license Out

VIEW MORE >

Collaborative Pipelines

Bio-customization Strategy Risk-hedged Joint Pipeline Development Strategy– ‘PIDO’

VIEW MORE >

OUR SCIENCE

BIODRONE TECHNOLOGY

MDimune Inc. wishes to make a healthier and happier world by developing innovative therapeutics.